Kaiser Permanente, the American Diabetes Association (ADA) and Bristol-Myers Squibb Co. are working together to expand the use of Archimedes, a computer simulation model that can be used to develop diabetes care programs.
Archimedes, developed a decade ago by Dr. David Eddy, senior adviser to Kaiser, and Dr. Len Schlessinger of Kaiser’s Care Management Institute, has been used for Kaiser’s southern California region. It has the ability to review large patient populations, which can aid healthcare organizations in developing clinical guidelines for diseases, evaluating quality of health care and examining the economic influence that prevention programs and treatments have on patients.
Bristol-Myers Squibb is providing $2.5 million in funding for the five-year partnership. According to Dr. Eddy, the group will first establish an international committee of diabetes experts who will review the diabetes care guidelines for Kaiser to implement this year.
“We can use this model to determine how many heart attacks could be prevented by lowering average blood-glucose levels, or for illustrating to patients how they can reduce their risk of complications by making gradual lifestyle changes,” Dr. Richard Kahn, chief scientific and medical officer for the ADA, says in a written statement.